Cargando…
Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233270/ https://www.ncbi.nlm.nih.gov/pubmed/37275680 http://dx.doi.org/10.1016/j.ymgmr.2023.100977 |
_version_ | 1785052202003333120 |
---|---|
author | Murko, Simona Peschka, Manuela Tsiakas, Konstantinos Schulz-Jürgensen, Sebastian Herden, Uta Santer, René |
author_facet | Murko, Simona Peschka, Manuela Tsiakas, Konstantinos Schulz-Jürgensen, Sebastian Herden, Uta Santer, René |
author_sort | Murko, Simona |
collection | PubMed |
description | We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant rise of neutrophil numbers. Liver transplantation alone did not produce the desired effect and our observation argues for continuing SGLT2 inhibitor treatment after transplantation. |
format | Online Article Text |
id | pubmed-10233270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102332702023-06-02 Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors Murko, Simona Peschka, Manuela Tsiakas, Konstantinos Schulz-Jürgensen, Sebastian Herden, Uta Santer, René Mol Genet Metab Rep Short Communication We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant rise of neutrophil numbers. Liver transplantation alone did not produce the desired effect and our observation argues for continuing SGLT2 inhibitor treatment after transplantation. Elsevier 2023-05-04 /pmc/articles/PMC10233270/ /pubmed/37275680 http://dx.doi.org/10.1016/j.ymgmr.2023.100977 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Murko, Simona Peschka, Manuela Tsiakas, Konstantinos Schulz-Jürgensen, Sebastian Herden, Uta Santer, René Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title | Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title_full | Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title_fullStr | Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title_full_unstemmed | Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title_short | Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors |
title_sort | liver transplantation in glycogen storage disease type ib: the role of sglt2 inhibitors |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233270/ https://www.ncbi.nlm.nih.gov/pubmed/37275680 http://dx.doi.org/10.1016/j.ymgmr.2023.100977 |
work_keys_str_mv | AT murkosimona livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors AT peschkamanuela livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors AT tsiakaskonstantinos livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors AT schulzjurgensensebastian livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors AT herdenuta livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors AT santerrene livertransplantationinglycogenstoragediseasetypeibtheroleofsglt2inhibitors |